Polymeric Biomaterials Market worth $16.93 billion by 2030
The report "Polymeric Biomaterials Market by Type (Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Polyetheretherketone, Other Polymeric Biomaterials), Application (Orthopedic, Dental, CVD) - Forecast to 2030” The polymeric biomaterials market is projected to reach USD 16.93 billion by 2030, from USD 11.83 billion in 2025, at a CAGR of 7.5%. The polymeric biomaterials market is experiencing growth, driven by several key factors such as broad adoption across medical devices, drug delivery systems, and tissue repair applications, and cost advantages compared to metallic and ceramic biomaterials in high-volume applications.
Browse 908 market data Tables and 50 Figures spread through 663 Pages and in-depth TOC on "Polymeric Biomaterials Market by Type (Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone Rubber, Nylon, Polyetheretherketone, Other Polymeric Biomaterials), Application (Orthopedic, Dental, CVD) - Forecast to 2030”
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/polymeric-biomaterials-market-164305934.html
The polymethyl methacrylate segment accounted for the largest share of the polymeric biomaterials market, by type, in 2024.
By type, the market is segmented into polymethylmethacrylate, polyethylene, polyester, polyvinylchloride, silicone rubber, nylon, polyetheretherketone, and other polymeric biomaterials. The polymethyl methacrylate (PMMA) segment accounted for the largest share of the polymeric biomaterials market in 2024, due to its long clinical history and versatile use in orthopedic bone cements, vertebroplasty fillers, intraocular lenses, and dental prosthetics. PMMA's combination of rigidity, optical clarity, radiopacity, and well-characterized biocompatibility keeps it the preferred option over many alternative medical polymers.
The orthopedic segment is projected to be the fastest-growing application during the forecast period.
By application, the market is segmented into cardiovascular, orthopedic, dental, and other applications. The orthopedic application is the fastest-growing segment of the polymeric biomaterials market. Rising volumes of joint-replacement and spinal procedures, greater use of polymer-based bone cements, spacers, and PEEK or UHMW-PE components, and expanding indications in trauma and sports medicine are driving the steepest increase in demand from orthopedic surgeons and device manufacturers.
North America accounted for the largest share of the polymeric biomaterials market in 2024.
The market for polymeric biomaterials is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America had the highest share of the polymeric biomaterials market in 2024. It is leading due to its concentration of advanced hospitals, orthopedic facilities, and cardiac institutes, as well as manufacturers of medical equipment, which are polymer-based implants, scaffolding structures, and drug delivery devices. Attainable reimbursement, strong R&D investment, and heavy investment in the areas of regenerative medicines and minimally invasive surgery further reinforce North America's leading position in the polymeric biomaterials market.
Key players in the polymeric biomaterials market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex PLC (UK), and Noble Biomaterials (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Polymeric Biomaterials Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
